New Insights in the Management of Resectable Esophageal Malignancy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 1421
Special Issue Editors
Interests: esophageal cancer; gastric cancer; personalized medicine; surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Esophageal cancer still remains a challenging disease worldwide despite the advances in the diagnosis and treatment. Resectable esophageal malignancy is currently treated through a multimodal and individualized approach consisting of perioperative chemotherapy, radiotherapy, immunotherapy and radical surgical resection. Evolution of the diagnostic tools available through artificial intelligence is a promising field, whereas minimally invasive surgical techniques aim to improve the perioperative outcomes. Furthermore, the investigation of the pathologic response to the perioperative therapies is also gaining popularity in the literature.
This Special Issue will focus on the current challenges in the diagnosis of the disease including new insights in radiomics, the role of the pathologist in the evaluation of the response to treatment as well as the evolving technical modalities regarding the surgical treatment options.
Dr. Tania Triantafyllou
Dr. Dimitrios A. Theodorou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- esophageal cancer
- perioperative chemotherapy
- radiotherapy
- immunotherapy
- radical surgical resection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
